Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 2877178)

Published in World J Gastroenterol on May 28, 2010

Authors

Mitsuro Chiba1, Toru Abe, Hidehiko Tsuda, Takeshi Sugawara, Satoko Tsuda, Haruhiko Tozawa, Katsuhiko Fujiwara, Hideo Imai

Author Affiliations

1: Division of Gastroenterology, Nakadori General Hospital, 3-15, Misono-cho, Minami-dori, Akita 010-8577, Japan. mchiba@meiwakai.or.jp

Articles citing this

Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol (2013) 1.75

Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology (2015) 1.40

Association of dietary type with fecal microbiota in vegetarians and omnivores in Slovenia. Eur J Nutr (2013) 0.99

Food and the gut microbiota in inflammatory bowel diseases: a critical connection. Curr Opin Gastroenterol (2012) 0.98

Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases. Mol Nutr Food Res (2016) 0.85

Nutrition in Pediatric Inflammatory Bowel Disease: From Etiology to Treatment. A Systematic Review. Nutrients (2016) 0.84

Response to strict and liberalized specific carbohydrate diet in pediatric Crohn's disease. World J Gastroenterol (2016) 0.82

High amount of dietary fiber not harmful but favorable for Crohn disease. Perm J (2015) 0.82

Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol (2016) 0.82

Fecal Microbiota in Healthy Subjects Following Omnivore, Vegetarian and Vegan Diets: Culturable Populations and rRNA DGGE Profiling. PLoS One (2015) 0.79

Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients. Int J Mol Sci (2016) 0.79

Onset of Ulcerative Colitis during a Low-Carbohydrate Weight-Loss Diet and Treatment with a Plant-Based Diet: A Case Report. Perm J (2016) 0.79

Plant-based diets in Crohn's disease. Perm J (2014) 0.78

Nutritional supplementation and dietary restriction in the resolution of enthesitis-related arthritis. JRSM Short Rep (2011) 0.78

Onset of Ulcerative Colitis after Helicobacter pylori Eradication Therapy: A Case Report. Perm J (2016) 0.77

From low-residue diets to plant-based diets in inflammatory bowel disease. Dig Dis Sci (2014) 0.77

Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease. Int J Mol Sci (2016) 0.76

Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol (2016) 0.76

The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflamm Res (2017) 0.75

An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease. Nutrients (2017) 0.75

The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol (2016) 0.75

Flexitarian Diets and Health: A Review of the Evidence-Based Literature. Front Nutr (2017) 0.75

Development and Application of a Plant-Based Diet Scoring System for Japanese Patients with Inflammatory Bowel Disease. Perm J (2016) 0.75

Bioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases-Promises, Perspectives, and Pitfalls. Oxid Med Cell Longev (2016) 0.75

The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75

Which Environmental Factors Cause IBD Relapses? Dig Dis Sci (2015) 0.75

Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention. Nutrients (2017) 0.75

Influence of Diet on the Course of Inflammatory Bowel Disease. Dig Dis Sci (2017) 0.75

Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease. Inflamm Bowel Dis (2017) 0.75

Articles cited by this

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet (2002) 14.14

Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol (2006) 7.75

Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med (1994) 5.46

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology (2000) 5.34

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology (2004) 5.19

Dysbiosis in inflammatory bowel disease. Gut (2004) 5.01

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology (2003) 4.40

Guidelines for the management of inflammatory bowel disease in adults. Gut (2004) 4.15

Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology (2008) 3.98

Persistence of health habits and their relationship to mortality. Prev Med (1980) 3.94

Management of Crohn's disease in adults. Am J Gastroenterol (2009) 3.94

Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut (1996) 3.94

Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology (1979) 3.94

Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology (2008) 3.89

European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59

Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med (1996) 3.47

Genome-based prediction of common diseases: advances and prospects. Hum Mol Genet (2008) 3.45

Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology (1995) 3.44

Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095). Br J Nutr (1999) 3.40

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology (2006) 3.32

The nutrition transition in low-income countries: an emerging crisis. Nutr Rev (1994) 3.18

Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J (1979) 2.93

Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology (1997) 2.22

A controlled double blind study of azathioprine in the management of Crohn's disease. Gut (1995) 2.00

The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol (1991) 1.88

Food intolerance and Crohn's disease. Gut (1993) 1.84

Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol (1998) 1.80

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology (2006) 1.78

Crohn's disease: maintenance of remission by diet. Lancet (1985) 1.70

The genetics of inflammatory bowel disease. Gastroenterology (2007) 1.66

Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroenterol (2002) 1.63

Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum (2000) 1.54

Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut (2008) 1.54

Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis (2005) 1.52

Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr (1996) 1.49

Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet. Br Med J (1979) 1.39

Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci (1997) 1.33

Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: A randomized-controlled trial. Aliment Pharmacol Ther (2006) 1.31

The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. J Clin Gastroenterol (1988) 1.31

A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Dig Dis Sci (2008) 1.26

Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol (2007) 1.26

Comparison of the fecal microflora in rural Japanese and urban Canadians. Microbiol Immunol (1986) 1.23

Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol (1995) 1.12

Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials. Am J Gastroenterol (2005) 1.10

Diet and inflammatory bowel disease: a case-control study. Epidemiology (1992) 1.09

Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion (1993) 1.08

Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut (1995) 1.05

Dietary patterns and risk for Crohn's disease in children. Inflamm Bowel Dis (2008) 1.04

Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. Br Med J (Clin Res Ed) (1987) 1.01

Convergence of plant-rich and plant-only diets. Am J Clin Nutr (1999) 0.99

Dietary and other risk factors of ulcerative colitis. A case-control study in Japan. Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Clin Gastroenterol (1994) 0.97

Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group). Scand J Gastroenterol (1996) 0.95

Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn's disease. Gastroenterol Jpn (1993) 0.91

Effect of a high-beef diet on the fecal bacterial flora of humans. Cancer Res (1977) 0.91

A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr (1998) 0.88

Effect of rice fiber on human fecal microflora. Microbiol Immunol (1989) 0.86

Three Japanese cases of inflammatory bowel disease associated with left-sided colonic diverticulosis: its implication. Inflamm Bowel Dis (2005) 0.84

Convergence of philosophy and science: the third international congress on vegetarian nutrition. Am J Clin Nutr (1999) 0.82

Esophageal ulcer of Crohn's disease: disappearance in 1 week with infliximab. Inflamm Bowel Dis (2009) 0.79

Articles by these authors

Clinical significance of high-Km 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome. Leuk Res (2007) 1.50

Correlation of visual recovery and presence of photoreceptor inner/outer segment junction in optical coherence images after successful macular hole repair. Retina (2008) 1.45

Macular abnormalities in patients with retinitis pigmentosa: prevalence on OCT examination and outcomes of vitreoretinal surgery. Acta Ophthalmol (2011) 1.40

Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2003) 1.34

Changes of fundus autofluorescence, photoreceptor inner and outer segment junction line, and visual function in patients with retinitis pigmentosa. Clin Experiment Ophthalmol (2010) 1.18

Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study. J Rheumatol (2004) 1.09

Association of ambient air pollution and meteorological factors with primary care visits at night due to asthma attack. Environ Health Prev Med (2013) 0.99

Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development. Surgery (2002) 0.98

Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis. J Rheumatol (2006) 0.96

Lfng regulates the synchronized oscillation of the mouse segmentation clock via trans-repression of Notch signalling. Nat Commun (2012) 0.93

Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy. J Rheumatol (2004) 0.92

Missing environmental factor in inflammatory bowel disease: diet-associated gut microflora. Inflamm Bowel Dis (2011) 0.90

Endoscopic mucosal resection using a cap-fitted panendoscope and endoscopic submucosal dissection as optimal endoscopic procedures for superficial esophageal carcinoma. Surg Endosc (2011) 0.89

The astrocyte-targeted therapy by Bushi for the neuropathic pain in mice. PLoS One (2011) 0.89

Clinical and biological significance of CD56 antigen expression in acute promyelocytic leukemia. Leuk Lymphoma (2004) 0.86

VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts. Cardiovasc Res (2003) 0.85

Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet (2004) 0.85

Development of atherosclerosis in osteopontin transgenic mice. Heart Vessels (2002) 0.85

Topical isopropyl unoprostone for retinitis pigmentosa: microperimetric results of the phase 2 clinical study. Ophthalmol Ther (2012) 0.83

Efficacy of vitrectomy and internal limiting membrane removal for macular edema associated with branch retinal vein occlusion. Ophthalmologica (2009) 0.83

Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma. Graefes Arch Clin Exp Ophthalmol (2012) 0.83

High-mobility semiconducting naphthodithiophene copolymers. J Am Chem Soc (2010) 0.83

Acute alcohol withdrawal accompanied by posterior reversible encephalopathy syndrome. Psychiatry Clin Neurosci (2013) 0.81

Adenovirus-mediated gene transfer of ICOSIg fusion protein ameliorates ongoing experimental autoimmune myocarditis. Hum Gene Ther (2003) 0.81

Changes of electroretinogram without improvement of retinal circulation after radial optic neurotomy for central retinal vein occlusion. ERG changes after RON for CRVO. Doc Ophthalmol (2008) 0.80

Long-term combined therapy with an angiotensin type I receptor blocker and an angiotensin converting enzyme inhibitor prolongs survival in dilated cardiomyopathy. Jpn Heart J (2002) 0.80

CD30 and the NPM-ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma. Am J Hematol (2002) 0.80

Crohn's disease successfully treated with infliximab in a patient receiving hemodialysis: case report and review of the literature. Medicine (Baltimore) (2014) 0.80

Association of electroretinogram and morphological findings in branch retinal vein occlusion with macular edema. Doc Ophthalmol (2011) 0.79

Lansoprazole-associated collagenous colitis: diffuse mucosal cloudiness mimicking ulcerative colitis. World J Gastroenterol (2009) 0.79

Improvement of central retinal sensitivity six months after topical isopropyl unoprostone in patients with retinitis pigmentosa. Indian J Ophthalmol (2013) 0.79

Association between PM2.5 and primary care visits due to asthma attack in Japan: relation to Beijing's air pollution episode in January 2013. Environ Health Prev Med (2013) 0.79

Esophageal ulcer of Crohn's disease: disappearance in 1 week with infliximab. Inflamm Bowel Dis (2009) 0.79

Different distribution of Dukes' stage between proximal and distal colorectal cancer. Hepatogastroenterology (2002) 0.79

A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression. Hypertens Res (2003) 0.79

Evaluation of contrast visual acuity in patients with retinitis pigmentosa. Clin Ophthalmol (2011) 0.78

Intrathecal landiolol inhibits nociception and spinal c-Fos expression in the mouse formalin test. Can J Anaesth (2007) 0.78

Altered microvasculature is involved in remodeling processes in cardiomyopathic hamsters. Jpn Heart J (2003) 0.77

Successful treatment with cyclosporine and high-dose gamma immunoglobulin for persistent parvovirus B19 infection in a patient with refractory autoimmune hemolytic anemia. Int J Hematol (2004) 0.77

Vitrectomy alone versus vitrectomy with simultaneous intravitreal injection of triamcinolone for macular edema associated with branch retinal vein occlusion. Ophthalmic Surg Lasers Imaging (2009) 0.76

Cytomegalovirus infection associated with onset of ulcerative colitis. BMC Res Notes (2013) 0.76

Clonal evolution of blasts in an elderly patient with CD56(+) relapsed acute promyelocytic leukemia. Am J Hematol (2002) 0.76

Ophthalmoplegia associated with transorbital penetrating brainstem injury by broken fishing pole. Clin Ophthalmol (2011) 0.75

Association of diverticular colitis and inflammatory bowel disease. Dig Endosc (2010) 0.75

Cutaneous aspergillosis in a patient with follicular lymphoma. Eur J Dermatol (2003) 0.75

[Pretreatment with lidocaine accelerates onset of vecuronium-induced neuromuscular blockade]. Masui (2002) 0.75

[Progress in the study of allergy and collagen disease in the last 100 years: Concept of collagen disease]. Nihon Naika Gakkai Zasshi (2002) 0.75

Compound heterozygous mutations (p.Leu13Pro and p.Tyr294*) associated with factor VII deficiency cause impaired secretion through ineffective translocation and extensive intracellular degradation of factor VII. Thromb Res (2012) 0.75

Hydration structures of lactic acid: characterization of the ionic clathrate hydrate formed with a biological organic acid anion. Phys Chem Chem Phys (2014) 0.75

[Patient-controlled epidural analgesia combined with patient-controlled intravenous analgesia for postoperative analgesia after Miles' operation for rectal cancer]. Masui (2011) 0.75

Giant pigment epithelial tear after scleral buckling for rhegmatogenous retinal detachment. Retin Cases Brief Rep (2008) 0.75

Rapid proliferation of a different clone early after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Int J Hematol (2002) 0.75

[Collagen diseases and rheumatic diseases]. Nihon Naika Gakkai Zasshi (2004) 0.75

Erratum to: Topical Isopropyl Unoprostone for Retinitis Pigmentosa: Microperimetric Results of the Phase 2 Clinical Study. Ophthalmol Ther (2013) 0.75

S-nitrosylated polyethylene glycol-conjugated hemoglobin derivative as a candidate material for oxygen therapeutics. Adv Exp Med Biol (2003) 0.75

Changes in multifocal oscillatory potentials after internal limiting membrane removal for macular hole: multifocal OPs after ILM removal. Doc Ophthalmol (2007) 0.75

Impact of isomeric structures on transistor performances in naphthodithiophene semiconducting polymers. J Am Chem Soc (2011) 0.75

Successful non-surgical treatment of brain abscess and necrotizing fasciitis caused by Bacillus cereus. Intern Med (2002) 0.75

Therapeutic endoscopic retrograde cholangiopancreatography using a large dilating balloon in a patient with upside-down stomach and bile duct stones (with video). J Hepatobiliary Pancreat Sci (2014) 0.75

[LETTER]. Nippon Ganka Gakkai Zasshi (2016) 0.75

[Complications of hematopoietic stem cell transplantation and the treatment: infections]. Nihon Naika Gakkai Zasshi (2005) 0.75